Clinical Trial Update: Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies [Phase 2]

View source ↗

Summary

Phase II study of oxaliplatin and capecitabine in advanced head and neck cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Louisville | Conditions: Head or Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-31